May 19, 2026 – Johnson & Johnson announced the global launch of its Shockwave C2 Aero Coronary IVL Catheter designed for improved deliverability, enhanced lesion crossing and new repositioning capabilities for the treatment of calcified coronary artery disease (CAD).
The next-generation coronary IVL catheter leverages Shockwave IVL’s unique mechanism of action and the safety and effectiveness profile of its legacy catheters, expanding the company’s market-leading IVL portfolio.
Shockwave C2 Aero provides physicians with greater flexibility and efficiency in treatment strategy by:
- Enhancing deliverability through tight, tortuous arteries via more flexible shaft, balloon and marker bands.
- Easing entry and crossing of dense calcified deposits with its tapered tip and new hydrophilic coating.
- Allowing repositioning within the coronary anatomy to treat additional lesions due to the new balloon material designed for more compact deflation.
Shockwave C2 Aero has a working length of 138 centimeters and features two emitters encased in an integrated balloon that fire simultaneously up to 120 pulses, delivering up to 240 Shockwaves. Each Shockwave pulse creates ultrasonic acoustic pressure waves that pass through soft tissue and crack hardened calcium in place, helping to re-establish blood flow in the blocked artery.
Shockwave C2 Aero is now available in the United States and Japan and will be available in Europe and Canada in the coming months.